@article{oai:repo.lib.tut.ac.jp:00001077,
 author = {藤原, 孝男 and FUJIWARA, Takao},
 issue = {4},
 journal = {研究技術計画, The journal of science policy and research management},
 month = {May},
 note = {An introductory and short explanation is summarized here for following five papers from the U.S.A., Germany, India, China, and Japan. Main topics include the reason of attention to biopharmaceutical industry, the global trend of commercialization of life science, the characteristics of advanced countries as the U.S.A. and Europe and of emerging countries as India and China, and Japan's trend of number of biotech start-ups, business areas, and venture capital., rights: 研究・技術計画学会
rights: 本文データは学協会の許諾に基づきCiNiiから複製したものである
relation：isVersionOf: http://ci.nii.ac.jp/naid/110007227605/},
 pages = {299--306},
 title = {バイオ産業の課題と展望(<特集>生命科学の事業化)},
 volume = {23},
 year = {2009}
}